Clinical Data Management White Paper & Articles

  1. IRT vs. RTSM: What Sponsors Need To Know When Choosing Clinical Trial Technology 5/6/2026

    Mastering the nuances between IRT and RTSM allows trial teams to move past confusing jargon and focus on the supply intelligence and randomization logic essential for study integrity.

  2. What The Joint FDA And EMA's AI Principles Can Mean For Clinical Trial Technology 5/6/2026

    New FDA/EMA principles align global expectations for AI in drug trials, emphasizing transparency, human-centric design, and risk-based governance to ensure data integrity and patient safety.

  3. General Wellness Isn't A Vibe Anymore: What The 2026 FDA Update Means 4/6/2026

    The FDA’s 2026 guidance has put an end to "wellness by disclaimer." Learn how new standards for wearables and apps impact study design, participant safety, and the evolving ethical role of the IRB.

  4. Bringing Local Payments To International Clinical Trials 3/18/2026

    Modernize clinical trials by replacing slow international wires with local digital payments. Reduce participant friction and ensure fair, instant reimbursements across the globe.

  5. Top 10 HEOR Trends Report 3/16/2026

    Emerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.

  6. 2026 State Of Clinical Trial Technology: The Five Strategic Imperatives 3/12/2026

    AI acceleration and digital fragmentation are reshaping clinical trials. Discover five imperatives driving interoperability, smarter site enablement, and data‑ready workflows for future‑ready operations.

  7. Rethinking RTSM Software: When Bigger Isn't Better 3/9/2026

    Don’t let legacy vendor inertia jeopardize your trial. Discover why agility and deep RTSM expertise are the new benchmarks for reducing risk and ensuring precision in clinical operations.

  8. Policy To Practice: PBM Reform, TrumpRx, And Global Drug Development 3/4/2026

    Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.

  9. The Innovations Shaping 2026 CNS Clinical Trials 2/27/2026

    Explore how AI, digital tools, and site‑centered design can reduce burden, strengthen data quality, and support more reliable trial execution.

  10. RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It Matters 2/25/2026

    Explore why RTSM should be viewed as a system for managing change. Learn how platform-based reusability reduces UAT churn, preserves institutional memory, and stabilizes mid-study amendments.